This page lists the SEC filings reported by Samjo Capital LLC.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2023-02-10 | Samjo Capital LLC | HTG MOLECULAR DIAGNOSTICS, INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-10 | Samjo Capital LLC | Societal CDMO, Inc. | 4,050,000 | 4.8% | EDGAR |
SC 13G/A | 2023-02-10 | Samjo Capital LLC | ITERIS, INC. | 3,280,000 | 7.7% | EDGAR |
SC 13G/A | 2022-02-08 | Samjo Capital LLC | Recro Pharma, Inc. | 3,200,000 | 6.9% | EDGAR |
SC 13G/A | 2022-02-08 | Samjo Capital LLC | HTG MOLECULAR DIAGNOSTICS, INC | 590,000 | 7.8% | EDGAR |
SC 13G/A | 2022-02-08 | Samjo Capital LLC | Research Solutions, Inc. | 1,280,000 | 4.8% | EDGAR |
SC 13G/A | 2022-02-08 | Samjo Capital LLC | NEPHROS INC | 425,000 | 4.2% | EDGAR |
SC 13G | 2022-02-07 | Samjo Capital LLC | ITERIS, INC. | 2,525,000 | 6.0% | EDGAR |
SC 13G | 2021-07-16 | Samjo Capital LLC | Recro Pharma, Inc. | 2,350,000 | 5.1% | EDGAR |
SC 13G | 2021-02-16 | Samjo Capital LLC | Research Solutions, Inc. | 1,460,000 | 5.6% | EDGAR |
SC 13G/A | 2021-02-11 | Samjo Capital LLC | Research Solutions, Inc. | 800,000 | 3.0% | EDGAR |
SC 13G/A | 2021-02-11 | Samjo Capital LLC | HTG MOLECULAR DIAGNOSTICS, INC | 381,713 | 8.1% | EDGAR |
SC 13G | 2020-10-21 | Samjo Capital LLC | NEPHROS INC | 550,000 | 5.6% | EDGAR |
SC 13G/A | 2020-02-04 | Samjo Capital LLC | Research Solutions, Inc. | 1,323,482 | 5.4% | EDGAR |
SC 13G | 2020-01-31 | Samjo Capital LLC | HTG MOLECULAR DIAGNOSTICS, INC | 3,300,000 | 5.7% | EDGAR |
SC 13G/A | 2019-02-12 | Samjo Capital LLC | Research Solutions, Inc. | 1,350,000 | 5.6% | EDGAR |
SC 13G/A | 2018-01-25 | Samjo Capital LLC | Research Solutions, Inc. | 1,442,109 | 6.0% | EDGAR |
SC 13G | 2017-06-22 | Samjo Capital LLC | Research Solutions, Inc. | 1,197,344 | 5.0% | EDGAR |
SC 13G/A | 2017-02-10 | Samjo Capital LLC | ARI NETWORK SERVICES INC /WI | 941,800 | 5.4% | EDGAR |
SC 13G/A | 2016-02-12 | Samjo Capital LLC | Digimarc CORP | 380,200 | 4.3% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.